Viking Therapeutics (VKTX) SEC Filings & 10K Form

$75.42
+1.11 (+1.49%)
(As of 04/29/2024 ET)

Recent Viking Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2024
7:42 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:05 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:15 PM
Viking Therapeutics (Filer)
Form ARS
03/27/2024
7:50 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:51 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:52 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:08 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
6:50 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:52 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:54 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:52 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
3:05 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
4:21 PM
Viking Therapeutics (Filer)
Form 424B5
02/27/2024
6:04 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
7:59 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:38 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
6:40 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:24 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2024
4:33 PM
Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/31/2024
7:39 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:32 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
8:05 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:23 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
12:24 PM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
01/19/2024
7:35 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:36 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
3:26 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
01/04/2024
8:35 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:36 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:37 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:22 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:24 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:25 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:27 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:28 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:12 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
3:30 PM
VIKING GLOBAL INVESTORS LP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G
10/25/2023
4:05 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2023
3:24 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
3:23 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2023
5:30 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)

A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...

This strange new device to protect us against that A.I. threat...
05/18/2023
5:31 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
4:36 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2023
3:39 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2023
4:00 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
6:03 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
12:48 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VKTX) was last updated on 4/30/2024 by MarketBeat.com Staff

From Our Partners